Clinical Trials Directory

Trials / Completed

CompletedNCT02814240

Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging

Hepatic Steatosis and Pituitary Gland Failure, Evaluation by NMR Imaging

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigator put forward the hypothesis that liver fat mass in patients with pituitary gland failure is greater than that in a control population. Failure of the anterior pituitary and more particularly impaired production of growth hormone (GH) could be the principal mechanism responsible for increased liver fat mass in these patients.

Conditions

Interventions

TypeNameDescription
OTHERNMR
BIOLOGICALBlood samples
OTHERfibroscan

Timeline

Start date
2015-03-16
Primary completion
2015-10-10
Completion
2015-10-10
First posted
2016-06-27
Last updated
2024-02-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02814240. Inclusion in this directory is not an endorsement.

Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging (NCT02814240) · Clinical Trials Directory